GreenSHeart has been invited to the Collision Conference Alpha Program, joining an international group of founders addressing some of healthcare's most urgent challenges. The Toronto gathering convenes more than 40,000 participants with represented expertise across AI, digital therapeutics, hospital innovation, and venture investment.
Our inclusion in the Alpha cohort provides deep access to mentorship, product clinics, and curated matchmaking with global leaders in cardiology and health systems. We will showcase the GreenSHeart remote monitoring platform, demonstrating how predictive pathways and clinician support tools can scale to diverse populations across ASEAN and beyond.
Meet the full Alpha class on the Collision Conference showcase and connect with us onsite to explore collaborative clinical trials, strategic partnerships, or health equity initiatives.
